Objective: To determine preferences for HPV-based cervical cancer screening among South African women.
Methods: A discrete choice experiment survey was conducted among 298 women who attended two public-sector clinics in South Africa from February 1 to May 31, 2018. Participants chose between hypothetical screening scenarios: method of swab collection (self or provider); timing of treatment (same day or return visit); type of clinic (static or mobile); cost of services (US $0 or US $4); and time spent at the clinic (30, 60, or 120 minutes). A logistic regression model was generated to evaluate the importance of each attribute. A market simulation analysis was performed to determine potential uptake of the various screening strategies.
Results: The participants expressed strong preferences for free services (β=0.50; P<0.001) and same-day HPV testing and treatment (β=0.40; P<0.001). The market simulation indicated that 83.8% of women would be willing to undergo screening if services were free; the swab was collected by the provider; and treatment was offered at a return visit. Including same-day testing and treatment in the model increased uptake to 96.4%.
Conclusion: Offering same-day HPV testing and treatment could substantially improve uptake of cervical cancer screening in the South African public healthcare sector.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610705 | PMC |
| http://dx.doi.org/10.1002/ijgo.12869 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human papillomavirus DNA detection in cervical samples from women of reproductive age in Mogadishu, Somalia.
J Infect Dev Ctries
November 2024
Department of Urology, Faculty of Medicine, and Health Sciences, SIMAD University, Mogadishu, Somalia.
Introduction: Somalia is among the countries with a high burden of human papillomavirus (HPV) infection in Sub-Saharan Africa. In 2022, 660,000 infections are reported among women globally, out of which 350,000 died from the disease. Most of the studies on HPV reported from Somalia are based on cytologic analysis which is a subjective and suboptimal assessment.
View Article and Find Full Text PDFSelf-Collection for HPV-Based Cervical Screening: Knowledge and Attitudes of Australian Health Care Workers in an Area With Low Screening Rates, July-November 2023.
Public Health Rep
December 2024
Epidemiology and Health Analytics, Research and Education Network, Western Sydney Local Health District, North Parramatta, NSW, Australia.
Article Synopsis
- - Cervical screening is key for early detection of cervical cancer, but traditional methods face issues like embarrassment and accessibility, making self-collection a viable alternative to increase screening rates among underserved populations.
- - A recent survey of Australian healthcare workers revealed gaps in their understanding of self-collection methods, along with a preference for clinician collection and concerns about patients’ willingness to use self-collection.
- - To improve participation in cervical screening, especially among those who are under- or never-screened, comprehensive education and accessible resources about self-collection are necessary to address knowledge gaps and build patient confidence.
2024 Hong Kong College of Obstetricians and Gynaecologists Guidelines for cervical cancer prevention and screening.
Hong Kong Med J
December 2024
Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong SAR, China.
Primary prevention of cervical cancer is best achieved by vaccinating girls with a prophylactic human papillomavirus (HPV) vaccine. Despite the high efficacy of such vaccines, cervical cancer screening remains necessary because current vaccines do not offer full protection. Secondary prevention via cervical screening should target all women from age 25 years or at the onset of sexual activity, whichever occurs later, until age 64 years.
View Article and Find Full Text PDFUnderstanding the cervical cancer self-collection preferences of women living in urban and rural Rwanda.
PLOS Glob Public Health
September 2023
School of Medicine and Pharmacy, University Teaching Hospital of Kigali, University of Rwanda, Kigali, Rwanda.
Cervical cancer is a leading cause of cancer among women in low- and middle-income countries. Women in Rwanda have high rates of cervical cancer due to limited access to effective screening methods. Research in other low-resource settings similar to Rwanda has shown that HPV-based self-collection is an effective cervical cancer screening method.
View Article and Find Full Text PDFTesting for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory.
J Clin Microbiol
August 2023
Centre for Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Twelve high-risk alpha human papillomavirus (HPV) genotypes cause approximately 690,000 cancer cases annually, with cervical and oropharyngeal cancer being the two most prominent types. HPV testing is performed in laboratory settings for various applications of a clinical, epidemiological, and research nature using a range of clinical specimens collected by clinicians or by individuals (self-collected specimens). Here, we reflect on the importance and justification of using the right test for the right application and provide practical updates for laboratories either participating in or anticipating involvement in HPV testing in three specimen types, namely, urine, blood, and oral specimens, which are considered "alternative" specimens by many.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!